¼¼°èÀÇ º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)
Global Beta Thalassemia Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
»óǰÄÚµå : 1342786
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2023³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 199 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç(Beta Thalassemia Testing) ½ÃÀå ¼ö¿ä´Â 2022³â 5,018¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. 2030³â 1Á¶ 2,146¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀ̸ç, 2023³âºÎÅÍ 2030³â±îÁö 9.2%ÀÇ CAGR ¼ºÀå·üÀ» º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

º£Å¸ ÁöÁßÇØºóÇ÷Àº Ç÷¾× ÁúȯÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. À̰ÍÀº ½Åü¿¡ »ý¼ºµÇ´Â Çì¸ð±Û·ÎºóÀÌ ÀϹݺ¸´Ù ÀûÀº À¯Àüº´ÀÔ´Ï´Ù. Çì¸ð±Û·ÎºóÀº öÀ» Æ÷ÇÔÇÏ´Â ´Ü¹éÁú·Î ÀûÇ÷±¸¿¡ Á¸ÀçÇÕ´Ï´Ù. Çì¸ð±Û·ÎºóÀÇ ÁÖ¿ä ±â´ÉÀº Àü½Å ü¼¼Æ÷¿¡ »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â °ÍÀÔ´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷Àº ¾öû³­ ¼öÀÇ Ç÷¾× ¼¼Æ÷°¡ ÆÄ±«µË´Ï´Ù. ÀÌ ÁúȯÀº ºóÇ÷, È£Èí °ï¶õ, ÇǷΰ¨, ºü¸¥ ½ÉÀå ¹Úµ¿, °ú¹Î¼º, Ȳ´Þ ¹× ¼ºÀå Áö¿¬À» Ư¡À¸·Î ÇÕ´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç¿¡´Â ¼öÇ÷°ú ö ų·¹ÀÌÆ® ¿ä¹ýÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

ÁöÁßÇØºóÇ÷ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÏ ¼ö ÀÖ½À´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷ ½ÃÀå ¼ºÀå·ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº °Ç°­ °ü¸® ÁöÃâ Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ Á¶±âÀ¯Àü °Ë»ç¿Í »ó´ã µµÀÔ·ü »ó½ÂÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÕ´Ï´Ù. ¶ÇÇÑ, ÁöÁßÇØºóÇ÷ ÀνÄÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎ Á¶Ä¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, R&D Ȱµ¿ Ȱ¼ºÈ­¿Í È¿°úÀûÀÎ Ä¡·á¹ý Ãâ½Ã´Â À¯¸®ÇÑ ½ÃÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ ¼³¹® Á¶»ç º¸°í¼­´Â Porter's Five Forces ºÐ¼® ¸ðÇü, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°è ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØÀÇ °æÀïµµ¸¦ Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç »ê¾÷ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼® :

ÀÌ ¼½¼ÇÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä« ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ª °³º° ÀÀ¿ë ºÐ¾ß ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì ±¸±Û¿¡ ¹®ÀÇ ¹Ù¶ø´Ï´Ù. ´ç»ç ¼³¹®Á¶»çÆÀÀº °í°´ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç-»ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå COVID-19 ¹ß»ý ¿µÇ⠺м®

Á¦6Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ¼¼°èÀÇ º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : ±â¼úº°

Á¦8Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦9Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ±â¾÷ °æÀï ±¸µµ

Á¦12Àå ±â¾÷ ÇÁ·ÎÇÊ

NJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for Beta Thalassemia Testing Market is presumed to reach the market size of nearly USD 1214.63 BN by 2030 from USD 501.83 BN in 2022 with a CAGR of 9.2% under the study period 2023 - 2030.

Beta thalassemia is a type of blood disorder. This is a genetic disease in which the body produces less haemoglobin than usual. Haemoglobin is a protein containing iron and is present in red blood cells; the major function of haemoglobin is to carry oxygen to the body cells throughout the body. Beta thalassemia causes a huge number of blood cells to be destroyed. The condition is characterized by anemia, shortness of breath, fatigue, fast heartbeat, irritability, jaundice, and slow growth. Beta thalassemia testing consists of blood transfusions and iron chelation therapy.

MARKET DYNAMICS:

The increase in the prevalence of thalassemia may be a major contributor to market growth. Another significant factor influencing the beta thalassemia market growth rate is the rising healthcare expenditure. Also, the rise in the adoption rate of early genetic testing and counselling will boost market growth. Moreover, government measures to raise awareness of thalassemia may propel market growth. Furthermore, increased R&D activities and the launch of effective treatments offer lucrative market opportunities. However, the high cost associated with the treatment may limit the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of beta thalassemia testing. The growth and trends of beta thalassemia testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the beta thalassemia testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

By Technology

By Type

By End-User

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Beta Thalassemia Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the beta thalassemia testing market include MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics Inc., Asper Biogene, Tosoh Bioscience Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

2 . EXECUTIVE SUMMARY

3 . BETA THALASSEMIA TESTING - INDUSTRY ANALYSIS

4 . VALUE CHAIN ANALYSIS

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY PRODUCT

7 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TECHNOLOGY

8 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TYPE

9 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY END-USER

10 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY GEOGRAPHY

11 . COMPETITIVE LANDSCAPE OF THE BETA THALASSEMIA TESTING COMPANIES

12 . COMPANY PROFILES OF BETA THALASSEMIA TESTING INDUSTRY

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â